Large-Bore Mechanic Thrombectomy for the Treatment of Symptomatic Portomesenteric Vein Thrombosis
NCT ID: NCT06318754
Last Updated: 2025-01-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2025-03-31
2027-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of Variceal Embolization Combined With Partial Splenic Artery Embolization for Variceal Bleeding in Cavernous Transformation of Portal Vein.
NCT07310316
The Study of Percutaneous Mechanical Thrombectomy Treating Acute Deep Vein Thrombosis of Lower Extremities
NCT05356767
Study of a Novel Thrombectomy Device to Treat Acute Iliofemoral Deep Venous Thrombosis
NCT02414802
TIPS or Anticoagulation in Portal Vein Thrombosis
NCT03422419
Outcome of Percutaneous Mechanical Thrombectomy to Treat Acute Deep Venous Thrombosis
NCT02959801
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Inari Triever Aspiration Catheter
Inari Triever Aspiration Catheter for portomesenteric venous thrombosis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* PMVT diagnosed on cross-sectional imaging such as contrast-enhanced CT or MRI abdomen
* Symptomatic PMVT (persistent symptom, worsening abdominal pain after initiation of anticoagulation, development of peritonitis, complication of portal hypertension in cirrhosis (variceal bleeding or worsening ascites), and poor surgical candidates
* Speaks and understands English language
Exclusion Criteria
* no PMVT diagnosed on cross-sectional imaging such as contrast-enhanced CT or MRI abdomen
* Malignant PMVT
* chronic PMVT including presence of cavernoma and network of prominent collateral vessels in porta hepatis on cross-sectional imaging.
* asymptomatic PMVT
* life expectancy \< 6 months
* Does not speak or understand English language
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Inari Medical
INDUSTRY
University of Maryland, Baltimore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Adam Fang
Assistant Professor of Diagnostic Radiology and Nuclear Medicine
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HP-00104241
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.